Cimpress releases FY2023 ESG Report

DUNDALK, Ireland--(BUSINESS WIRE)-- Cimpress plc (Nasdaq: CMPR) published its latest Environmental, Social, and Governance (ESG) Report, providing an in-depth overview of the company's advancements in environmental stewardship and social responsibility during the fiscal year 2023.

The ESG Report provides a comprehensive view of Cimpress' progress across critical sustainability areas, including greenhouse gas emissions, responsible forestry, reducing and improving our plastics, support of our small- and medium-sized business customers, team member engagement, diversity, equity and inclusion, workforce safety, and risk management.

The full report detailing Cimpress' sustainability initiatives, accomplishments, and future commitments is available on the Cimpress website at www.cimpress.com/about-us/csr/ and on its investor relations website at ir.cimpress.com.

About Cimpress

Cimpress plc (Nasdaq: CMPR) invests in and builds customer-focused, entrepreneurial, print mass-customization businesses for the long term. Mass customization is a competitive strategy which seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Cimpress businesses include BuildASign, Drukwerkdeal, Exaprint, National Pen, Pixartprinting, Printi, Vista, and WIRmachenDRUCK. To learn more, visit www.cimpress.com.

Cimpress and the Cimpress logo are trademarks of Cimpress plc or its subsidiaries. All other brand and product names appearing on this announcement may be trademarks or registered trademarks of their respective holders.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231214766238/en/

Investor Relations:
Meredith Burns
[email protected]
+1.781.652.6480

Media Relations:
Sara Litwiller
[email protected]

Source: Cimpress plc

You May Also Be Interested In

• STRONG Pilates Accelerates Global Momentum With Expansion Into Central and Eastern Europe; Announces Master Franchise Partnership With Xtreme Brands
• Northrop Grumman Enters Into $3 Billion Landmark Agreements to Accelerate Missile Interceptor Production
• Canon Medical Systems’ Olea Medical to Expand U.S. Access to eyonis® LCS for AI-Powered Lung Cancer Screening